Filter

Matching tags for Drug Delivery:

The Binding Finding of a Fluorescence Lifetime

In this afternoon’s session on Luminescence and Absorption on Cellular and Tissue Levels, Prof. Victor Chernomordik gave an overview of the extensive work he and his colleagues have been undertaking to make fluorescence molecular imaging more quantitative. Much of their work has focused specifically on how to quantify human epidermal growth factor receptor 2 (HER2) concentrations (a key...

Added:27 Apr 2014


Reducing Drug Trial Costs with Imaging Technology

95% of new cancer therapeutics fail to make it past Phase II clinical trials. This means that while it should only cost about $50 million per drug for FDA approval, incorporating the cost of failures leads to an estimated cost of $1 billion per drug (1), with a recent Forbes article suggesting that this number is considerably higher (2).So why are so many drugs failing in clinical trials?

Added:04 Mar 2014


Photoimmunotherapy (PIT) busts open the doors for drug delivery

Over the last decade alone, it is estimated that over $200 billion has been spent just by governments to fund cancer research [1]. Despite this enormous investment, the recently released 2014 World Heath Organization (WHO) Cancer Report suggests that cancer incidence rates and deaths from cancer are on the rise, both in more developed and less developed nations.

Added:06 Feb 2014